Fda Panel Endorses Johnson Johnson Covid 19 Booster Shot
If authorized, after the application for emergency use authorization at the beginning of October, the Johnson & Johnson booster would be available to people aged 18 and above who received the single-dose vaccine. “There is a public health imperative here, because what we’re seeing is that this is a group with overall lower efficacy than we have seen with the mRNA vaccine,” said Arnold S. Monto, MD, an epidemiology and public health professor at the University of Michigan School of Public Health....